Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000129587 | SCV000184370 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000241793 | SCV000304394 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000333429 | SCV000410744 | benign | Peutz-Jeghers syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000333429 | SCV000554120 | benign | Peutz-Jeghers syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129587 | SCV000686691 | benign | Hereditary cancer-predisposing syndrome | 2015-04-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000241793 | SCV000884612 | benign | not specified | 2018-07-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001580067 | SCV001895628 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000333429 | SCV002057437 | benign | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000241793 | SCV002552025 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149892 | SCV003838175 | benign | Breast and/or ovarian cancer | 2021-10-05 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000333429 | SCV004015559 | benign | Peutz-Jeghers syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000241793 | SCV000692050 | benign | not specified | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000129587 | SCV000788220 | likely benign | Hereditary cancer-predisposing syndrome | 2018-02-20 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001355314 | SCV001550171 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The STK11 p.Tyr272Tyr variant was not identified in the literature nor was it identified in the MutDB, LOVD 3.0, Zhejiang Colon Cancer Database, and Insight Hereditary Tumors Database databases. The variant was identified in dbSNP (ID: rs9282859) as “Other”, ClinVar (classified benign by Ambry Genetics and Prevention Genetics, and likely benign by Illumina), and in Cosmic (3X all in lung carcinomas). The variant was also identified in control databases in 2204 (84 homozygous) of 273338 chromosomes at a frequency of 0.008 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017), identified in the following populations at a frequency greater than 1%: African in 1993 of 23530 chromosomes (freq: 0.085). The p.Tyr272Tyr variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. | |
Genome Diagnostics Laboratory, |
RCV001580067 | SCV001809549 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000241793 | SCV001923010 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000241793 | SCV001958876 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000241793 | SCV002036443 | benign | not specified | no assertion criteria provided | clinical testing |